Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 May 1987:
Vol. 236. no. 4803, pp. 827 - 831
DOI: 10.1126/science.3033826
Prev | Table of Contents | Next

Articles

Science, Vol 236, Issue 4803, 827-831
Copyright © 1987 by American Association for the Advancement of Science

articles

Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa

PJ Kanki, S M'Boup, D Ricard, F Barin, F Denis, C Boye, L Sangare, K Travers, M Albaum, R Marlink, and al. et

A new human T-lymphotropic virus (HTLV-4) was recently described in healthy people from Senegal. This virus has many properties in common with members of the human T-lymphotropic viruses, particularly the human immunodeficiency virus or HIV, the etiologic agent of acquired immune deficiency syndrome (AIDS), but does not appear to be associated with immunodeficiency-related disorders. In the present study, serum samples were obtained from 4248 individuals from six West African countries, including Senegal, Guinea, Guinea Bissau, Mauritania, Burkina Faso, and Ivory Coast. These samples, collected during 1985-1987, were from people categorized as healthy control, sexually active risk, and disease populations. All samples were analyzed for reactivity to HTLV-4 and HIV by radioimmunoprecipitation-sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. Evidence for HTLV-4 infection was found in five of the six countries. The seroprevalence varied markedly from country to country. Healthy sexually active individuals in the risk category had the highest levels of HTLV-4 infection compared to individuals in the healthy control category and the disease category, the latter including AIDS patients. The seroprevalence of HIV infection in most of these countries was quite low, although tightly associated with the rare cases of AIDS. The biology of HTLV-4 infection thus differs from that of HIV in Central Africa or the United States and Europe. The presence of these viruses and their different pathogenicities in several countries of West Africa indicate the necessity for serologic assays that will distinguish between them. Further studies of their origin and distribution as well as of their biology will be important in advancing our understanding of AIDS.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Potent Neutralizing Serum Immunoglobulin A (IgA) in Human Immunodeficiency Virus Type 2-Exposed IgG-Seronegative Individuals.
Q. Lizeng, C. Nilsson, S. Sourial, S. Andersson, O. Larsen, P. Aaby, M. Ehnlund, and E. Bjorling (2004)
J. Virol. 78, 7016-7022
   Abstract »    Full Text »    PDF »
Human neutralizing human immunodeficiency virustype 2-specific Fab molecules generated by phage display.
E. Björling, E. von Garrelts, A. Mörner, M. Ehnlund, and M. A. A. Persson (1999)
J. Gen. Virol. 80, 1987-1993
   Abstract »    Full Text »
Natural protection against HIV-1 infection provided by HIV-2.
K Travers, S Mboup, R Marlink, A Gueye-Nidaye, T Siby, I Thior, I Traore, A Dieng-Sarr, J. Sankale, C Mullins, et al. (1995)
Science 268, 1612-1615
   Abstract »    PDF »
Human Immunodeficiency Virus Type 2 Infection in the United States: Epidemiology, Diagnosis, and Public Health Implications.
T. R. O'Brien, J. R. George, and S. D. Holmberg (1992)
JAMA 267, 2775-2779
   Abstract »    PDF »
Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression.
L. Evans, J Moreau, K Odehouri, H Legg, A Barboza, C Cheng-Mayer, and J. Levy (1988)
Science 240, 1522-1525
   Abstract »    PDF »
West African HIV-2-related human retrovirus with attenuated cytopathicity.
L. Kong, S. Lee, J. Kappes, J. Parkin, D Decker, J. Hoxie, B. Hahn, and G. Shaw (1988)
Science 240, 1525-1529
   Abstract »    PDF »
The Acquired Immunodeficiency Syndrome (AIDS) and Infection with the Human Immunodeficiency Virus (HIV).
HEALTH AND PUBLIC POLICY COMMITTEE (1988)
Ann Intern Med 108, 460-469
   Abstract »    PDF »
AIDS: an international perspective.
P Piot, F. Plummer, F. Mhalu, J. Lamboray, J Chin, and J. Mann (1988)
Science 239, 573-579
   Abstract »    PDF »
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.
J. Gnann Jr, J. McCormick, S Mitchell, J. Nelson, and M. Oldstone (1987)
Science 237, 1346-1349
   Abstract »    PDF »
Current Concepts in the Virology of Infection with Human Immunodeficiency Virus (HIV) A View from the III International Conference on AIDS.
J. A. HOXIE (1987)
Ann Intern Med 107, 406-408
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)